Restoration of neurological function following injury to the nervous system has long been the aim of neuroscientists and clinicians. The central nervous system (CNS) has proven to be an elusive target for restorative treatment. Although neuroprotective agents show promise, once injury to the brain o
Clinical trials of botulinum toxin in the treatment of spasticity
โ Scribed by David M. Simpson
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 101 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Botulinum toxin type A (BTX-A) has been shown to be a safe and effective treatment for focal or segmental muscle overactivity, including spasticity. Local injections of BTX-A are particularly valuable in relieving focal spasticity around a joint or a series of joints. When integrated into an overall
Spasticity from an upper motor neuron syndrome may cause a variety of symptoms that interfere with function. Decisions regarding spasticity treatment are influenced by the chronicity, severity, and distribution of the spasticity; the locus of injury; the presence and severity of co-morbidities; the